Jan 20 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS RECEIVES NOTICE OF TERMINATION FROM
BAUSCH
* CIPHER PHARMACEUTICALS - RECEIVED NOTICE OF TERMINATION
FROM
BAUSCH HEALTH RELATED TO LICENSE, DEVELOPMENT &
COMMERCIALIZATION AGREEMENT OF TRULANCE
* CIPHER PHARMACEUTICALS INC - NOTICE ALLEGES THAT CIPHER IS
IN
BREACH OF CERTAIN UNSPECIFIED PROVISIONS OF AGREEMENT
* CIPHER PHARMACEUTICALS INC - AS PART OF STRATEGIC REVIEW
PROCESS, CO WAS IN ACTIVE DISCUSSIONS TO SUB-LICENSE TRULANCE
WITH MULTIPLE PARTIES
* CIPHER PHARMACEUTICALS INC - INTENDS TO CHALLENGE THE
NOTICE OF
TERMINATION
Source text for Eikon: ID:nCNWK4GjLa
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))